Excellent response to rituximab in a patient with recalcitrant epidermolysis bullosa acquisita: a case report

Epidermolysis Bullosa Acquisita is a rare, chronic autoimmune blistering disorder characterized by vesicles and bullae on the skin and mucous membranes. This condition, presenting typically in adulthood, is caused by autoantibodies against type VII collagen. Conventional treatments, including system...

Full description

Bibliographic Details

Published in:	Journal of the Egyptian Women’s Dermatologic Society
Main Authors:	Fahad Alrashidi, Khalid Nabil Nagshabandi, Ruaa Alharithy
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-05-01
Subjects:	biologics epidermolysis bullosa acquisita rituximab
Online Access:	https://journals.lww.com/10.4103/jewd.jewd_109_24